Vincent R. Richard

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Dynamics and regulation of lipid droplet formation in lipopolysaccharide (LPS)-stimulated microglia

Armen Khatchadourian, Simon D. Bourque, Vincent R. Richard et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2012 · 143 citations

Life Sciences, Biochemistry, Immunology +12

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes

Alexander A. Goldberg, Vincent R. Richard, Pavlo Kyryakov et al. · Aging · 2010 · 117 citations · Full text

Education, Biochemistry, Genetics +12

A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability

Isabelle Sirois, Adriana Aguilar‐Mahecha, Josiane Lafleur et al. · Molecular Cancer Research · 2019 · 111 citations

Medicine, Cancer Biology, Oncology +15